Us Bancorp \De\ Provention Bio, Inc. Transaction History

Us Bancorp \De\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$6.7 - $24.21 $576 - $2,082	86 Added 51.5%	253 $6,000
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $754 - $1,765	167 New	167 $1,000
Q2 2022 Aug 01, 2022	SELL	$3.65 - $7.3 $1,901 - $3,803	-521 Reduced 14.8%	3,000 $12,000
Q4 2021 Feb 11, 2022	SELL	$5.59 - $7.39 $16,384 - $21,660	-2,931 Reduced 45.43%	3,521 $20,000
Q3 2021 Nov 10, 2021	BUY	$5.66 - $8.33 $1,205 - $1,774	213 Added 3.41%	6,452 $41,000
Q2 2021 Aug 05, 2021	BUY	$6.71 - $11.04 $8,313 - $13,678	1,239 Added 24.78%	6,239 $53,000
Q1 2021 Apr 28, 2021	BUY	$10.12 - $19.45 $20,240 - $38,900	2,000 Added 66.67%	5,000 $52,000
Q2 2019 Aug 13, 2019	BUY	$2.3 - $13.79 $6,899 - $41,370	3,000 New	3,000 $36,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.